↓ Skip to main content

Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy

Overview of attention for article published in Future Journal of Pharmaceutical Sciences, January 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
10 Mendeley
Title
Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
Published in
Future Journal of Pharmaceutical Sciences, January 2023
DOI 10.1186/s43094-023-00460-w
Authors

Roland Nnaemeka Okoro, Ado Danazumi Geidam, Audu Abdullahi Bukar, Abba Bukar Zarami, John David Ohieku, Alhaji Bukar Musa, Timothy Samuel Yerima

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 30%
Student > Postgraduate 1 10%
Student > Doctoral Student 1 10%
Unknown 5 50%
Readers by discipline Count As %
Unspecified 3 30%
Nursing and Health Professions 1 10%
Unknown 6 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2023.
All research outputs
#17,301,727
of 25,394,764 outputs
Outputs from Future Journal of Pharmaceutical Sciences
#40
of 96 outputs
Outputs of similar age
#269,283
of 472,192 outputs
Outputs of similar age from Future Journal of Pharmaceutical Sciences
#2
of 4 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 96 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 472,192 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.